Royce & Associates LP Sutro Biopharma, Inc. Transaction History
Royce & Associates LP
- $10.3 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding STRO
# of Institutions
132Shares Held
63.1MCall Options Held
205KPut Options Held
28.1K-
Suvretta Capital Management, LLC New York, NY7.46MShares$13.4 Million0.57% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$12.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.21MShares$7.53 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.64MShares$6.52 Million0.42% of portfolio
-
Vestal Point Capital, LP New York, NY2.57MShares$4.6 Million0.28% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $93.4M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...